Green Thumb Industries Inc. (CSE:GTII)
Canada · Delayed Price · Currency is CAD | Market Cap | 2.43B +41.8% |
| Revenue (ttm) | 1.67B +4.8% |
| Net Income | 169.24M +141.0% |
| EPS | 0.73 +147.4% |
| Shares Out | 219.03M |
| PE Ratio | 15.27 |
| Forward PE | 82.19 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 55,853 |
| Open | 11.00 |
| Previous Close | 11.18 |
| Day's Range | 10.98 - 11.41 |
| 52-Week Range | 6.54 - 14.39 |
| Beta | 0.95 |
| Analysts | Strong Buy |
| Price Target | 21.44 (+92.98%) |
| Earnings Date | Aug 5, 2026 |
About Green Thumb Industries
Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, tinctures, edibles, topicals, capsules, tinctures, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, RYM, and RHYTHM brands. It distributes its products to thir... [Read more]
Financial Performance
In 2025, Green Thumb Industries's revenue was $1.18 billion, an increase of 3.36% compared to the previous year's $1.14 billion. Earnings were $114.15 million, an increase of 56.20%.
Financial numbers in USD Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for GTII stock is "Strong Buy." The 12-month stock price target is $21.44, which is an increase of 92.98% from the latest price.
News
3 Leading Marijuana Stocks Investors Are Watching in June 2026
The cannabis sector continues evolving as operators focus on profitability, cash flow, and market expansion. Federal cannabis reform discussions remain a major catalyst. Meanwhile, leading multistate ...
3 Reasons to Buy Green Thumb Industries Like There's No Tomorrow
Green Thumb is better positioned to benefit from cannabis rescheduling than most cannabis companies.
The Single Biggest Cannabis Catalyst in Years Is Rapidly Approaching: 2 Marijuana Stocks to Buy Now
Green Thumb Industries and Tilray are in a strong position to benefit from the reclassification of cannabis as a Schedule III drug. Tilray is well positioned to expand its U.S. operations.
Better Buy: Green Thumb Industries vs. Curaleaf Holdings
In which of these cannabis stocks should investors plant their money?
3 Top Marijuana Stocks For Smarter Investing
Marijuana stock investors are trying to keep up with the ongoing changes the sector is going through. The cannabis industry inside the United States is evolving every day. Many of these changes can im...
Green Thumb Industries: Marijuana Meme Stock or Dream Stock?
It isn't easy to find a marijuana company that can turn a profit.
Is Green Thumb Becoming the "Procter & Gamble of Cannabis"?
Green Thumb is one of the few consistently profitable cannabis companies. Green Thumb and Procter & Gamble focus on quality brands.
3 Marijuana Stocks To Know About Now In 2026
The cannabis industry once again is going through some big changes. Nearly every state in the USA has some form of legal cannabis legislation. Now, with the recent passing of cannabis being considered...
Green Thumb Industries vs. Curaleaf Holdings: Which Cannabis Stock Could Win Biggest From DEA Rescheduling?
Is Green Thumb or Curaleaf better positioned to benefit from marijuana rescheduling?
Green Thumb Industries Slides: Investor presentation
Green Thumb Industries has posted slides in relation to its latest quarterly earnings report, which was published on May 11, 2026.
Green Thumb Industries price target raised to $10 from $8 at Benchmark
Benchmark raised the firm’s price target on Green Thumb Industries (GTBIF) to $10 from $8 and keeps a Buy rating on the shares after “a solid Q1” report. Published first…
Green Thumb Industries price target raised to C$25 from C$21 at Alliance Global
Alliance Global analyst Aaron Grey raised the firm’s price target on Green Thumb Industries (GTBIF) to C$25 from C$21 and keeps a Buy rating on the shares following the company’s…
Green Thumb Industries Earnings Call Transcript: Q1 2026
Q1 2026 revenue rose 7.5% year-over-year to $300 million, with normalized EBITDA at $93.5 million and record cash of $345 million. Share buybacks and disciplined capital allocation continued, while regulatory changes and new state licenses position the company for future growth.
Green Thumb Industries Earnings release: Q1 2026
Green Thumb Industries released its Q1 2026 earnings on May 6, 2026, summarizing the period's financial results.
Green Thumb Industries Reports First Quarter 2026 Results
CHICAGO and VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer...
Here Is How Marijuana Stocks Are Setting Up To Run In 2026
Investors foresee a potential rise in marijuana stocks leading to another green rush. Anyone who holds shares of cannabis stocks, whether US-based or Canadian, has been battling in the stock market. T...
Green Thumb Industries Files Applications for DEA Registration Following Historic Rescheduling of Medical Cannabis
CHICAGO and VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer ...
2 Medical Marijuana Stocks to Buy Now
Trulieve is the largest multi-state operator in the U.S., with more than 200 dispensaries. Green Thumb is the rare profitable pure-play cannabis company.
Prediction: Green Thumb Industries Stock Will Double Within 3 Years
Green Thumb is about as blue chip as it comes in the U.S. cannabis industry. The company has multiple potential catalysts that could drive its stock higher.
Marijuana Stocks: Industry Growth, Rescheduling Impact, and Outlook
The cannabis industry has become one of the most closely watched emerging sectors in global finance. As a result, marijuana stocks are attracting growing attention from both retail and institutional i...
3 Cannabis Stocks That Could Soar After Marijuana Rescheduling
Marijuana rescheduling can result in significant tax savings for multi-state operators (MSOs) in the U.S. Three of the largest MSOs are Curaleaf Holdings, Green Thumb Industries, and Trulieve Cannabis...
Marijuana Rescheduling Has Arrived. Don't Make This Mistake
Rescheduling is a positive milestone for the marijuana industry. It doesn't, however, legalize marijuana or mean that every pot stock will benefit from the news.
2 Top Marijuana Stocks For Investors Around The World
Most marijuana stocks saw a recent jump in trading across the board this past week. The reason for this was the official signing of the rescheduling of cannabis to Schedule 3. Although a great achieve...
The Cannabis Sector's Billion-Dollar Tax Cut
On the heels of the executive order to fast-track research into psychedelic drugs, a second major federal policy shift on April 23, 2026, is sending waves through the cannabis sector. However, the rea...
3 Marijuana Stocks To Watch In 2026 For Better Trading
The cannabis industry is in a big battle between corporate growth and the small batch family farmers who came before legalization. For legal small batch and craft farmers, there is a fight to keep ope...